We are live on ! Find out more
AssetMark Inc

AssetMark Inc Portfolio holdings

AUM $58.2B
1-Year Est. Return 22.78%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+22.78%
3 Year Est. Return
+68.16%
5 Year Est. Return
+68.87%
10 Year Est. Return
+184.44%
AUM
$27.7B
AUM Growth
+$2.66B
Cap. Flow
+$289M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.52%
Holding
2,033
New
292
Increased
959
Reduced
465
Closed
198
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
201
Alphabet (Google) Class C
GOOG
$4.08T
$20.6M 0.07%
145,834
+7,383
+5% +$1M
EMHY icon
202
iShares JPMorgan EM High Yield Bond ETF
EMHY
$619M
$20.5M 0.07%
563,182
+68,894
+14% +$2.38M
GWX icon
203
State Street SPDR S&P International Small Cap ETF
GWX
$862M
$20.3M 0.07%
640,629
-4,191
-0.6% -$123K
ABBV icon
204
AbbVie
ABBV
$455B
$20.2M 0.07%
130,447
+6,656
+5% +$970K
SPTI icon
205
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.5B
$20.1M 0.07%
704,864
-3,394,723
-83% -$94.2M
MS icon
206
Morgan Stanley
MS
$330B
$20.1M 0.07%
215,548
+15,837
+8% +$1.27M
VTWG icon
207
Vanguard Russell 2000 Growth ETF
VTWG
$1.48B
$20M 0.07%
109,201
-2,624
-2% -$430K
MDT icon
208
Medtronic
MDT
$110B
$19.9M 0.07%
241,650
+5,980
+3% +$456K
VWOB icon
209
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$19.6M 0.07%
307,475
+195,752
+175% +$11.8M
COST icon
210
Costco
COST
$423B
$19.2M 0.07%
29,057
-716
-2% -$424K
CVS icon
211
CVS Health
CVS
$134B
$18.7M 0.07%
236,472
-1,407
-0.6% -$100K
COP icon
212
ConocoPhillips
COP
$145B
$18.4M 0.07%
158,698
+15,655
+11% +$1.83M
EOG icon
213
EOG Resources
EOG
$77.5B
$18.1M 0.07%
149,704
+6,678
+5% +$831K
GLDM icon
214
SPDR Gold MiniShares Trust
GLDM
$27.9B
$18M 0.07%
440,083
-14,105
-3% -$553K
CVX icon
215
Chevron
CVX
$383B
$17.7M 0.06%
118,336
+2,825
+2% +$427K
PANW icon
216
Palo Alto Networks
PANW
$265B
$17.4M 0.06%
117,692
-12,740
-10% -$1.7M
LRCX icon
217
Lam Research
LRCX
$373B
$17.3M 0.06%
220,400
+34,540
+19% +$2.35M
AOR icon
218
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$17.3M 0.06%
324,385
-19,947
-6% -$1.01M
DFAU icon
219
Dimensional US Core Equity Market ETF
DFAU
$12.3B
$17.2M 0.06%
516,626
-5,257
-1% -$163K
NKE icon
220
Nike
NKE
$62.7B
$16.9M 0.06%
155,913
+29,930
+24% +$3.22M
PFFD icon
221
Global X US Preferred ETF
PFFD
$2.15B
$16.9M 0.06%
868,846
-21,090
-2% -$392K
GLD icon
222
SPDR Gold Trust
GLD
$133B
$16.8M 0.06%
88,057
+26,806
+44% +$4.91M
UPRO icon
223
ProShares UltraPro S&P 500
UPRO
$5.13B
$16.8M 0.06%
+306,731
New +$14.1M
CGDV icon
224
Capital Group Dividend Value ETF
CGDV
$37.4B
$16.6M 0.06%
557,568
+24,815
+5% +$684K
WFC icon
225
Wells Fargo
WFC
$258B
$16.6M 0.06%
336,533
+22,492
+7% +$971K

Similar funds

AssetMark Inc's Q4 2023 Portfolio in Review

As of Q4 2023, AssetMark Inc held 2,033 positions worth $27.7B, up 11% from $25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

AssetMark Inc's Q4 2023 filing shows 292 new, 959 increased, 465 reduced and 198 closed positions. Its largest new stake was Invesco Variable Rate Investment Grade ETF: 1,903,702 shares worth $47.6M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $393M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7% a quarter earlier, followed by Healthcare and Financials.

  • AssetMark Inc's largest Q4 2023 buy was Invesco Variable Rate Investment Grade ETF: 1,903,702 shares worth $47.6M.
  • AssetMark Inc added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $396M increase.
  • AssetMark Inc's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $393M.
  • AssetMark Inc fully exited Schwab Intermediately-Term US Treasury ETF in Q4 2023, selling an estimated $30.7M.
  • AssetMark Inc's ten largest holdings make up 30% of its $27.7B portfolio in Q4 2023.
  • AssetMark Inc opened 292 new positions and closed 198 in Q4 2023.
  • AssetMark Inc's portfolio value rose 11% quarter-over-quarter to $27.7B.

Based on AssetMark Inc's 13F filing for Q4 2023, filed 9 Feb 2024.